Compare Cardinal Health Inc (CAH) vs Quantum Computing Inc (QUBT) Price & Performance

Cardinal Health (CAH) trades at $236.87, down 0.13% on the day, near its 52-week high. The stock shows strong momentum with four consecutive quarterly EPS beats, including Q2 2026 EPS of $2.91 versus $2.42 expected. Technical indicators are bullish overall, with moving averages supporting upward trends. Revenue reached $222.58 billion in 2025, with net income margin improving to 0.67%.

Outlook remains positive driven by robust pharmaceutical demand and optimistic FY2027 guidance. Key risks include high debt levels and thin profit margins. Analysts maintain a bullish consensus with a $266.43 price target, representing 12.5% upside. The stock presents a growth opportunity but requires monitoring of margin pressures and cash flow volatility.

Quantum Computing Inc. (QUBT) trades at $8.91, down 0.22% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported Q2 2026 revenue of $5.6 million, a significant increase year-over-year, though it posted a net loss. Analyst sentiment is positive with a 75% buy rating and a consensus price target of $18.50, suggesting substantial upside potential from current levels.

QUBT presents high-risk, high-reward potential as it transitions to commercial scaling, with strong revenue growth offset by persistent losses and negative margins. Key risks include execution challenges in manufacturing expansion and intense competition in the quantum computing sector. The stock's valuation remains steep with a P/S ratio of 189.05, requiring careful monitoring of profitability improvements.